Global health knowledge is expanding faster than ever, but so are confusion and inequity over who can access trustworthy information and use it to improve their lives. In a live recorded discussion at the World Health Summit in Berlin, featured in the latest Global Health Matters podcast, Joy Phumaphi, executive secretary of the Africa Leaders […] Continue reading ->
The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading ->
WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading ->
The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading ->
GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading ->
NEW DELHI – The theme was “Scaling Access to Ensure Health Equity”, but that hardly reflected the intense concerns raised at the first World Health Summit regional meeting with the storm of Trump administration’s cutbacks and closures of global health programmes since January. Traditional medicine, climate and health, data transparency, and the role of artificial […] Continue reading ->
In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading ->
With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading ->
Only 35 countries have submitted the national strategies required by the UN biodiversity treaty showing how they’ll meet its binding nature protection targets. While 33 of these plans recognise links between human health and biodiversity, they offer few specifics on implementation and policy, a Health Policy Watch analysis found. Negotiators in Cali aim to bridge […] Continue reading ->
The Africa CDC has slammed the US government’s recent Level 3 travel advisory for Rwanda as unfair and baseless, arguing it undermines Rwanda’s proactive efforts to contain a Marburg outbreak. With rapid testing, vaccinations, and coordinated emergency response measures in place, Rwanda’s leaders insist the country poses no international threat and warn that travel restrictions […] Continue reading ->